Prior Stephen David bought ANTX
February 26, 2025 · Form 4 insider transaction
Prior Stephen David bought 56,000 shares of AN2 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
56,000
Price
$0.00
Total value
N/A
InsiderPrior Stephen David
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2025
Filing dateFebruary 28, 2025
Shares owned after56,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2025, subject to the Reporting Person's continuous service as of such date.